Horan Capital Advisors, Llc. Regeneron Pharmaceuticals, Inc. Transaction History

Horan Capital Advisors, Llc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$478.3 - $607.98 $81,311 - $103,356	-170 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$544.75 - $658.21 $92,607 - $111,895	170 New	170 $95,000
Q1 2020 Apr 29, 2020	SELL	$336.18 - $494.43 $57,150 - $84,053	-170 Closed	0 $0
Q3 2019 Oct 22, 2019	BUY	$273.46 - $318.39 $46,488 - $54,126	170 New	170 $47,000
Q2 2019 Jul 26, 2019	SELL	$299.6 - $414.82 $50,932 - $70,519	-170 Closed	0 $0
Q1 2019 Apr 22, 2019	BUY	$372.08 - $439.57 $63,253 - $74,726	170 New	170 $70,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Horan Capital Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Horan Capital Advisors, Llc. with notifications on news.